Directory
>
Meghan Miller
Meghan Miller
Executive Director, Translational Biomarkers | Skyhawk Therapeutics
Basel, Basel-City, Switzerland
Meghan Miller
Summary
Meghan Miller is an accomplished executive in the biotechnology field, currently serving as the Executive Director of Translational Biomarkers at Skyhawk Therapeutics in Basel, Switzerland. With a strong background in biochemistry and molecular biology, she has led significant advancements in biomarker discovery and translational research. Her previous roles at Roche involved leading research teams focused on rare diseases, where she successfully managed cross-functional collaborations and clinical development strategies. Meghan's educational foundation includes a PhD in Biomedical Sciences from UC San Diego, complemented by a BA in Mathematics from Colgate University. She is recognized for her ability to bridge scientific research with clinical applications, making her a key player in the commercial physical research industry. Her passion for innovation and patient-centered outcomes drives her commitment to advancing healthcare solutions. Outside of her professional endeavors, Meghan is likely to engage in community initiatives that promote science education and research accessibility.
Meghan Miller
Work Experience
Executive Director, Translational Biomarkers at
Skyhawk Therapeutics
April 2024 - Present
Sr. Director, Discovery/Translational Biology at
Skyhawk Therapeutics
May 2023 - June 2024
Director, Discovery/Translational Biology at
Skyhawk Therapeutics
May 2021 - May 2023
Assoc. Director of Translational Biology, Neurobiology at
Skyhawk Therapeutics
September 2019 - May 2021
Head of Research, Rare Diseases at
Roche
February 2019 - August 2019
Senior Project Leader, Rare Diseases at
Roche
November 2017 - February 2019
Discovery Project Leader, Rare Diseases at
Roche
September 2015 - November 2017
Postdoctoral Research Associate at
Roche
February 2012 - August 2015
Postdoctoral Research Associate at
University Of California San Diego
January 2010 - January 2011
PhD student - Biomedical Sciences, Pharmacology at
University Of California San Diego
January 2004 - January 2010
HHMI Med-into-Grad Fellow at
University Of California San Diego
January 2008 - January 2008
Pre-IRTA Fellow at
The National Institutes of Health
January 2003 - January 2004
Pre-IRTA Fellow at
The National Institutes of Health
January 2002 - January 2003
Meghan Miller
Education
UC San Diego School of Medicine, Phd
Frequently Asked Questions about Meghan Miller
What is Meghan Miller email address?
Meghan Miller's primary email address is ******@skyhawktx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Meghan Miller work for?
Meghan Miller is a Executive Director, Translational Biomarkers at Skyhawk Therapeutics, a company specializing in Commercial physical research.
Where Meghan Miller graduated from?
Meghan Miller holds a degree in Biomedical Sciences, Pharmacology from UC San Diego School of Medicine.
How can I directly contact Meghan Miller?
To contact Meghan Miller directly, you can use the email address ******@skyhawktx.com. Complete contact information is available upon registration with Muraena.
Who is Meghan Miller?
Meghan Miller is an accomplished executive in the biotechnology field, currently serving as the Executive Director of Translational Biomarkers at Skyhawk Therapeutics in Basel, Switzerland. With a strong background in biochemistry and molecular biology, she has led significant advancements in biomarker discovery and translational research. Her previous roles at Roche involved leading research teams focused on rare diseases, where she successfully managed cross-functional collaborations and clinical development strategies. Meghan's educational foundation includes a PhD in Biomedical Sciences from UC San Diego, complemented by a BA in Mathematics from Colgate University. She is recognized for her ability to bridge scientific research with clinical applications, making her a key player in the commercial physical research industry. Her passion for innovation and patient-centered outcomes drives her commitment to advancing healthcare solutions. Outside of her professional endeavors, Meghan is likely to engage in community initiatives that promote science education and research accessibility.
Meghan`s contact details
******@skyhawktx.com
Colleagues
Chief Scientific Officer
Vice-President, Chemistry, Skyhawk Therapeutics
Vice President Corporate Development
Executive Director, Bioinformatics
Chief Medical Officer
Senior Vice President Chemistry
Senior Vice President Legal
Executive Director Discovery Biology